MedPath
HSA Product

Tenox Tablets 10 mg

Product approved by Health Sciences Authority (SG)

Basic Information

Tenox Tablets 10 mg

TABLET

Regulatory Information

SIN14547P

May 19, 2014

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XC08CA01

Company Information

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

Detailed Information

Contraindications

**4.3 Contraindications** Amlodipine is contraindicated in patients with a known hypersensitivity to dihydropyridines\* or any of the inert ingredients. \\* Amlodipine is a dihydropyridine calcium channel blocker.

Indication Information

**4.1 Therapeutic indications** Hypertension Amlodipine is indicated for the first-line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, alpha blockers, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme (ACE) inhibitor. Coronary Artery Disease _Chronic Stable Angina_ Amlodipine is indicated for the symptomatic treatment of chronic stable angina. Amlodipine may be used alone or in combination with other antianginal drugs. _Vasospastic Angina (Prinzmetal’s or Variant Angina)_ Amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine may be used as monotherapy, or in combination with other antianginal drugs. _Angiographically Documented Coronary Artery Disease_ In patients with recently documented coronary artery disease (CAD) by angiography and without heart failure or an ejection fraction <40%, amlodipine is indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure.

© Copyright 2025. All Rights Reserved by MedPath